Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
Status:
Terminated
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
Phase 2a multicenter, randomized, double-blind, placebo-controlled study to assess the
pharmacodynamics, efficacy, and safety of tetomilast in patients with emphysema.
Phase:
Phase 2
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.